BlackRock Institutional Trust Company, N.A. - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 39 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$13,000
+8.3%
11,0520.0%0.00%
Q3 2016$12,000
+9.1%
11,0520.0%0.00%
Q2 2016$11,000
-15.4%
11,0520.0%0.00%
Q1 2016$13,000
-23.5%
11,0520.0%0.00%
Q4 2015$17,000
+30.8%
11,052
+84.7%
0.00%
Q3 2015$13,000
-31.6%
5,983
+56.6%
0.00%
Q2 2015$19,0003,8200.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
EAM Investors, LLC 670,593$3,401,0000.45%
Prospera Financial Services Inc 184,100$236,0000.05%
HighTower Advisors, LLC 1,047,731$1,257,0000.01%
TWO SIGMA SECURITIES, LLC 15,142$18,0000.01%
TEACHERS ADVISORS, LLC 298,781$1,820,0000.00%
TIAA CREF INVESTMENT MANAGEMENT LLC 724,455$4,412,0000.00%
Virtu KCG Holdings LLC 90,490$109,0000.00%
FIRST FOUNDATION ADVISORS 10,000$12,0000.00%
Acrospire Investment Management LLC 2,300$3,0000.00%
Balentine LLC 55$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders